Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis

References

• Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76(5):521–542. doi:10.1016/s0014-4835(03)00050-2
   PubMed Web of Science ®Google Scholar
• Al-Aqaba MA, Fares U, Suleman H, Lowe J, Dua HS. Architecture and distribution of human corneal nerves. Br J Ophthalmol. 2010;94(6):784–789. doi:10.1136/bjo.2009.173799
   PubMed Web of Science ®Google Scholar
• Stepp MA, Tadvalkar G, Hakh R, Pal-Ghosh S. Corneal epithelial cells function as surrogate Schwann cells for their sensory nerves. Glia. 2017;65(6):851–863. doi:10.1002/glia.23102
   PubMed Web of Science ®Google Scholar
• Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos EC. Neurotrophic keratitis: current challenges and future prospects. Eye Brain. 2018;10:37–45. doi:10.2147/EB.S117261
   PubMed Web of Science ®Google Scholar
• Al-Aqaba MA, Anis FS, Mohammed I, Dua HS. Nerve terminals at the human corneoscleral limbus. Br J Ophthalmol. 2018;102(4):556–561. doi:10.1136/bjophthalmol-2017-311146
   PubMed Web of Science ®Google Scholar
• Dua HS, Said DG, Messmer EM, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107–131. doi:10.1016/j.preteyeres.2018.04.003
   PubMed Web of Science ®Google Scholar
• Lambiase A, Rama P, Aloe L, Bonini S. Management of neurotrophic keratopathy. Curr Opin Ophthalmol. 1999;10(4):270–276.
   PubMedGoogle Scholar
• Semeraro F, Forbice E, Romano V, et al. Neurotrophic keratitis. Ophthalmologica. 2014;231(4):191–197. doi:10.1159/000354380
   PubMed Web of Science ®Google Scholar
• Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571–579. doi:10.2147/OPTH.S45921
   PubMedGoogle Scholar
• Puca A, Meglio M, Vari R, Tamburrini G, Tancredi A. Evaluation of fifth nerve dysfunction in 136 patients with middle and posterior cranial fossae tumors. Eur Neurol. 1995;35(1):33–37. doi:10.1159/000117086
   Web of Science ®Google Scholar
• Hyndiuk RA, Kazarian EL, Schultz RO, Seideman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol. 1977;95(12):2193–2196. doi:10.1001/archopht.1977.04450120099012
   Google Scholar
• Mastropasqua L, Massaro-Giordano G, Nubile M, Sacchetti M. Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves. J Cell Physiol. 2017;232(4):717–724. doi:10.1002/jcp.25623
   PubMed Web of Science ®Google Scholar
• Cruzat A, Qazi Y, Hamrah P. In vivo confocal microscopy of corneal nerves in health and disease. Ocul Surf. 2017;15(1):15–47. doi:10.1016/j.jtos.2016.09.004
   PubMed Web of Science ®Google Scholar
• dell’Omo R, Cifariello F, De Turris S, et al. Confocal microscopy of corneal nerve plexus as an early marker of eye involvement in patients with type 2 diabetes. Diabetes Res Clin Pract. 2018;142:393–400. doi:10.1016/j.diabres.2018.06.010
   Web of Science ®Google Scholar
• Moein HR, Kheirkhah A, Muller RT, Cruzat AC, Pavan-Langston D, Hamrah P. Corneal nerve regeneration after herpes simplex keratitis: a longitudinal in vivo confocal microscopy study. Ocul Surf. 2018;16(2):218–225. doi:10.1016/j.jtos.2017.12.001
   Web of Science ®Google Scholar
• Lagali NS, Allgeier S, Guimaraes P, et al. Reduced corneal Nerve fiber density in type 2 diabetes by wide-area mosaic analysis. Investigative Ophthalmology & Visual Science. 2017;58(14):6318–6327. doi:10.1167/iovs.17-22257
   Web of Science ®Google Scholar
• Lambiase A, Sacchetti M, Bonini S. Nerve growth factor therapy for corneal disease. Curr Opin Ophthalmol. 2012;23(4):296–302. doi:10.1097/ICU.0b013e3283543b61
   PubMed Web of Science ®Google Scholar
• Lambiase A, Mantelli F, Sacchetti M, Rossi S, Aloe L, Bonini S. Clinical applications of NGF in ocular diseases. Archives Italiennes De Biologie. 2011;149(2):283–292. doi:10.4449/aib.v149i2.1363
   PubMed Web of Science ®Google Scholar
• Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. NEngJMed. 1998;338:1174–1180. doi:10.1056/NEJM199804233381702
   PubMed Web of Science ®Google Scholar
• Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107(7):1347–1351; discussion 1351–1342. doi:10.1016/s0161-6420(00)00163-9
   Web of Science ®Google Scholar
• Smith RE, Sadun AA. Clearing the cornea with nerve growth factor. N Engl J Med. 1998;338(17):1222–1223. doi:10.1056/NEJM199804233381710
   Web of Science ®Google Scholar
• Ferrari MP, Mantelli F, Sacchetti M, et al. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial. BioDrugs. 2014;28(3):275–283. doi:10.1007/s40259-013-0079-5
   PubMed Web of Science ®Google Scholar
• Bonini S, Lambiase A, Rama P, et al. Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1468–1471. doi:10.1016/j.ophtha.2018.03.004
   PubMed Web of Science ®Google Scholar
• Bradshaw RA, Pundavela J, Biarc J, Chalkley RJ, Burlingame AL, Hondermarck H. NGF and ProNGF: regulation of neuronal and neoplastic responses through receptor signaling. Advances in Biological Regulation. 2015;58:16–27. doi:10.1016/j.jbior.2014.11.003
   Google Scholar
• Sacchetti M, Bruscolini A, Lambiase A. Cenegermin for the treatment of neurotrophic keratitis. Drugs of Today (barcelona, Spain : 1998). 2017;53(11):585–595. doi:10.1358/dot.2017.53.11.2722395
   Web of Science ®Google Scholar
• Nishida T, Yanai R. Advances in treatment for neurotrophic keratopathy. Current Opinion in Ophthalmology. 2009;20:276–281.
   PubMed Web of Science ®Google Scholar
• Kruse FE, Tseng SC. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Investigative Ophthalmology & Visual Science. 1993;34(6):1963–1976.
   PubMed Web of Science ®Google Scholar
• Reichard M, Hovakimyan M, Guthoff RF, Stachs O. In vivo visualisation of murine corneal nerve fibre regeneration in response to ciliary neurotrophic factor. Exp Eye Res. 2014;120:20–27. doi:10.1016/j.exer.2013.12.015
   PubMed Web of Science ®Google Scholar
• Lambiase A, Bonini S, Manni L, et al. Intraocular production and release of nerve growth factor after iridectomy. Investigative Ophthalmology & Visual Science. 2002;43(7):2334–2340.
   PubMed Web of Science ®Google Scholar
• Qi H, Chuang EY, Yoon KC, et al. Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions. Mol Vis. 2007;13:1934–1941.
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Beuerman RW, Thompson HW, DiLoreto DA. Growth factor and neurotrophic factor mRNA in human lacrimal gland. Cornea. 1997;16(2):192–199.
   Web of Science ®Google Scholar
• Ghinelli E, Johansson J, Rios JD, et al. Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland. Investigative Ophthalmology & Visual Science. 2003;44(8):3352–3357. doi:10.1167/iovs.03-0037
   Web of Science ®Google Scholar
• Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Current Opinion in Neurobiology. 2001;11(3):272–280. doi:10.1016/s0959-4388(00)00208-7
   PubMed Web of Science ®Google Scholar
• Bonini S, Lambiase A, Rama P, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1332–1343. doi:10.1016/j.ophtha.2018.02.022
   PubMed Web of Science ®Google Scholar
• Sacchetti M, Lambiase A, Schmidl D, et al. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study. Br J Ophthalmol. 2019. doi:10.1136/bjophthalmol-2018-312470
   Web of Science ®Google Scholar